Member Info for jona35

Sounds like a vampire story except my holding doing very well here over the last six month and will continue to hold

Personally I would be very careful at the moment i am not buying any more untill the fund raise because in this market ..I think its going to be at 1p with cln and warrant's just my opinion as i see it

It can take months to churn the placement shares like it has on apta ..Not saying this is a bad company but its clear that the placing shares are holding it back just like apta ..In fact due to idiots deramping apta on advfn this came to my attention. Futher research is needed from me but i have got to say i agrree with bill it does look good here..Guess deramping on other boards creates interest .You will certainly know when i buy in

Well i would wait for the raise no point in throwing good money now..If the placing come at a massive discount like it has for other companys on aim it could get a whole lot worse. The trouble then is you will have lots of share flips ..but looking at it now i would expect forward selling is going on so unfortunately its not looking good ..I only have a small punt here as lets face it .It was a gamble and we lost ..But I am going to wait for the placing and then wait until i feel is hit the bottom but all just my opinion and not investment advice

Another very disapointing day i did say this would happen..

Holding up nicely here slowly slowly we will rise

Looking at the trading and L2 it does seem there is now a down trend next week should confirm this as the bears take hold

Goes the dead duck ..until sanderson is gone nobodys interested here

Personably I would wait for the placing it will be at discount to the current share price then you need to watch and wait for the shares to be flipped ..imo ..You should know that when it get near the placing price .that the time to buy if you believe in the company ..just my opinion

The past month just wondering why ?

After listing to the bod very comfortable with my investment. I personally feel they truly has shareholders backs if and when the market allows ..gla

Really happy to have a balanced view its healthy . But I really do thing big contacts are being worked and around the corner . Why else were people in the business buying up the stock ?

Under the new management team, and with cash on the balance sheet, we have seen a significant improvement in customer confidence. The pipeline of opportunities that are at advanced stages of discussion currently stands at a healthy £3.3 million across 28 unique projects (subject to commercial and scientific attrition). Since the completion of the refinancing, we are encouraged to have added 128 new leads to a growing pool of opportunities which gives management confidence that significant orders will be signed before the 2023 calendar year end.

6 November trading update RNS There words not mine .Not long before the end of the year to take a position

Says GBP cant see anywhere where its says GBX click the link or ask AI on bing .I don't post anything false never would and all my posts are fully researched

Https://www.bing.com/search?q=aptamer%20group%20plc%20broker%20targets&qs=SYC&showconv=1&sendquery=1&FORM=ASCHT2&sp=11&ghc=1&lq=0

I found a document that contains the full year results for the twelve months ended 30 June 2023 of Aptamer Group plc 1. According to the document, the company’s revenue for the period was £1.8 million, and the adjusted EBITDA loss was £4.7 million. The company has signed contracts with a top five pharmaceutical company to develop multiple Optimer® binders as immunohistochemistry (IHC) reagents to support pipeline development and early discovery targets. The company has also signed multiple deals with Novavax, a vaccine developer for respiratory diseases, who require Optimer® binders to improve the selectivity of their Quality Control (QC) assays. Additionally, the company has signed multiple deals (and expanded) with a multinational consumer goods company for Optimer® binders supporting the development of novel direct-to-consumer personal care products. The company has also launched Optimer®-Fc tools to enable immunohistochemistry research and diagnostic workflows 1.

I also found a website that provides target price consensus and analysts recommendations for Aptamer Group plc. The average target price is 1.800 GBP, and the high price target is 1.800 GBP

Aptamer Group

@AptamerGroup

·

32m

Download our application guide to learn how #Optimer binders enable accurate and sensitive #biosensor development for chemotherapeutic targets.

https://shorturl.at/yFTUZ

Personally who would want to go there at the moment

Love the who great track

Just be careful of a possible pre placement rise 30 years in the game gla